Pitch Perfect 2025
Pitch Perfect is a Temerty Faculty of Medicine and Health Innovation Hub initiative at the University of Toronto, held to celebrate and support student entrepreneurs working on health focused innovations.
The event will showcase six student-based ventures who will have just five minutes to capture their innovative concept as they pitch to a panel of expert judges. Three of the teams will win a $5000 Student Innovation Fellowship to help develop their project further.
Join us in-person on November 12th for networking and interaction with the community! Food and refreshments will be provided.
Pitch Perfect 2025 is generously supported by the Temerty Faculty of Medicine and City of Toronto’s Business Incubation & Commercialization Grant Program.
Meet the Judges
Faizah leads the design and delivery of programming for the Black Founders Network, helping to build and support Black-led startups. She is passionate about creating authentic connections and fostering continuous learning. As a quantum enthusiast, she is also exploring ways to use quantum technology for social good, believing that early engagement is key to shaping its future.
Liam Kaufman | Executive VP, Partnerships and Strategic Projects, Cambridge Cognition
Liam Kaufman is the EVP of partnerships and strategic projects at Cambridge cognition. Previously he was the cofounder and CEO of Winterlight Labs, which developed digital biomarkers to quantify cognitive impairment and mental health using speech and machine learning. Winterlight Labs was acquired by Cambridge Cognition in 2023.
Liz Munro | President, Liz Munro Consulting Inc.
Liz is a medical device development expert with 15+ years of experience in innovative medical technology business. Currently, she acts as a fractional executive and product development + regulatory advisor to a small number of MedTech startups, as well as a Principal Consultant at Avania and MedTech Growth Coach at Communitech.
She previously served as Vice President of the Regulatory and Advisory Services practice at Avania, a leading med-tech focused global CRO, where she assisted clients with product development, regulatory and clinical strategy for novel medical products in diverse clinical application areas.
Prior to her work at Avania, she was the Chief Operating Officer of Ironstone Product Development, Canada’s only full-service medical device consulting group (acquired by Avania in 2023). Liz was the co-founder of an imaging-based breast margin assessment company, Perimeter Medical Imaging AI (TSXV:PINK), where she built the medical device development program from the ground up, achieved FDA clearance of four products and Breakthrough Device Designation, and designed and oversaw clinical studies involving more than 400 patients. Liz played a key role in raising nearly $40M in dilutive and non-dilutive capital and achieved a $200M+ market cap following a reverse takeover to list the company on the TSX Venture exchange in 2020, enabling liquidity for early investors. Liz understands the trade-offs and considerations that early-stage companies need to make in order to succeed.
She holds a Bachelor of Science (Honours) in Physics from McGill University, a Masters of Applied Science in Biomedical Engineering from the University of Toronto, and an MBA Essentials from the University of Toronto – Rotman School of Management.
Dr. Yasaman Soudagar | Co-Founder and Former CEO of Neurescence (acquired by Bruker)
Dr. Yasaman Soudagar completed her PhD in the field of experimental quantum optics at École Polytechnique of Montreal and the University of Toronto, under supervision of Dr. Aephraim Steinberg. She then worked at Attodyne (now Light Matter Interaction after a successful exit) as an industrial postdoc, designing the optical delivery of a surgical laser. In 2014 she had the idea for multi-region brain imaging for understanding the brain. She did a few months postdoc at a neuroscience lab and started her first company Neurescence. Neurescence went through a high profile acquisition by Bruker last November. Dr. Soudagar is now co-Founder and CEO of her second startup, currently in stealth mode. So stay tuned.
Meet the Finalists
Allowide Health develops a bioactive bone graft buffer that enhances tissue regeneration, helps patients recover faster, and simplifies graft preparation for healthcare professionals
ComfiDental Labs Inc. is a Toronto-based dental innovation startup developing ComfiDam, the world’s first breathable rubber dam designed to make isolation safer and more comfortable for both dentists and patients.
HER2HER is an at-home saliva test that promotes early-stage breast cancer awareness.
NephroTech is an award-winning MedTech startup that recently represented Canada at the Hult Prize Global Accelerator, ranking Top 20 out of 15,000 student startups worldwide, with its flagship device, DialySnake , the world’s first medical device that safely unblocks peritoneal dialysis catheters at patients’ bedsides, preventing costly and risky surgery.
With our unique AI and Matrix-Pinhole Image Sensing (MAPIS) technology, TechInu is turning diabetes care into what it should be: proactive, personalized, and pain-free.
Vrit develops a handheld bioprinting and bioengineered skin platform for autograft-free treatment of severe skin wounds in both civilian and defence settings.